Journal article
Olopatadine ophthalmic solution adjunctive to loratadine compared with loratadine alone in patients with active seasonal allergic conjunctivitis symptoms
Abstract
BACKGROUND: Olopatadine ophthalmic solution 0.1% (Patanol, Alcon Laboratories, Fort Woth, TX) is approved for the treatment of the signs and symptoms of allergic conjunctivitis. Loratadine 10 mg (Claritin, Schering-Plough, Madison, NJ) is a nonsedating oral antihistamine approved for the treatment of the signs and symptoms of allergic rhinitis.
OBJECTIVE: To compare the efficacy of olopatadine used adjunctively with loratadine versus loratadine …
Authors
Lanier BQ; Gross RD; Marks BB; Cockrum PC; Juniper EF
Journal
Annals of Allergy Asthma & Immunology, Vol. 86, No. 6, pp. 641–648
Publisher
Elsevier
Publication Date
June 2001
DOI
10.1016/s1081-1206(10)62292-2
ISSN
1081-1206